These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 28723775)

  • 21. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
    Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
    Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.
    Ruscitti P; Iacono D; Ciccia F; Emmi G; Cipriani P; Grembiale RD; Perosa F; Emmi L; Triolo G; Giacomelli R; Valentini G
    J Rheumatol; 2018 Jun; 45(6):864-872. PubMed ID: 29657144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease.
    Wakabayashi K; Inokuma S; Matsubara E; Onishi K; Asashima H; Nakachi S; Hagiwara K
    Clin Rheumatol; 2013 Jul; 32(7):999-1005. PubMed ID: 23504210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
    Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
    Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus.
    Hirooka Y; Okuda S; Sugiyama M; Shiga T; Nozaki Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2022; 13():822169. PubMed ID: 35116046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
    Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
    BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult-onset Still's disease.
    Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
    Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
    Kirino Y; Kawaguchi Y; Tada Y; Tsukamoto H; Ota T; Iwamoto M; Takahashi H; Nagasawa K; Takei S; Horiuchi T; Ichida H; Minota S; Ueda A; Ohta A; Ishigatsubo Y
    Mod Rheumatol; 2018 Sep; 28(5):858-864. PubMed ID: 29278009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult-onset Still's disease presenting as fever of unknown origin: a single-center retrospective observational study from China.
    Zhang M; Wang Y; Li J; Zhou J
    Ann Palliat Med; 2020 Sep; 9(5):2786-2792. PubMed ID: 32921079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
    Kim HA; An JM; Nam JY; Jeon JY; Suh CH
    J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delta neutrophil index as an early marker for differential diagnosis of adult-onset Still's disease and sepsis.
    Park HJ; Ha YJ; Pyo JY; Park YB; Lee SK; Lee SW
    Yonsei Med J; 2014 May; 55(3):753-9. PubMed ID: 24719144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.
    Yang JW; Lee E; Seo JY; Jung JY; Suh CH; Kim HA
    Pediatr Rheumatol Online J; 2018 Jan; 16(1):9. PubMed ID: 29370863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latent class analysis of 216 patients with adult-onset Still's disease.
    Sugiyama T; Furuta S; Hiraguri M; Ikeda K; Inaba Y; Kagami SI; Kita Y; Kobayashi K; Kobayashi Y; Kurasawa K; Nakagomi D; Nawata Y; Kawasaki Y; Shiko Y; Sugiyama T; Nakajima H
    Arthritis Res Ther; 2022 Jan; 24(1):7. PubMed ID: 34980244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposal of a new diagnostic algorithm for adult-onset Still's disease.
    Daghor-Abbaci K; Ait Hamadouche N; Makhloufi CD; Mechid F; Otmani F; Makrelouf M; Otmane A; Smail N; Boucelma M; Aissat FZ; Lefkir-Teffiani S; Bengana B; Boukheris N; Tebaibia A; Taharbouchet B; Ayoub S; Benziane B; Oumnia N; Haouichet C; Hanni F; Laraba N; Hakem D; Benfenatki N; Berrah A
    Clin Rheumatol; 2023 Apr; 42(4):1125-1135. PubMed ID: 36694091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
    Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
    J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline clinical features predicting macrophage activation syndrome in patients with systemic adult-onset Still's disease receiving interleukin-6 inhibitor treatment.
    Naniwa T; Yamabe T; Ohmura SI; Uehara K; Tamechika SY; Maeda S; Isogai S; Wada J
    Int J Rheum Dis; 2022 Sep; 25(9):1003-1012. PubMed ID: 35719030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult-onset Still's disease: how to make a diagnosis in an atypical case.
    Hu Q; Yan Z; Zhong J
    Rheumatol Int; 2012 Oct; 32(10):3299-302. PubMed ID: 21877245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.
    Yang XP; Wang M; Li TF; Li W; Zhang L; Liu SY
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):83-88. PubMed ID: 31287402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.